CUR 61414

inhibits the hedehog signaling pathway; structure in first source

Also Known As:

CUR-61414; CUR61414; G-024586

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

1.	Williams, Juliet A: 1 article (12/2003)

1.	Neoplasms (Cancer) 12/01/2003 - "CUR-61414 was reported to prevent the proliferation and selectively induce the death of the tumor cells, while not harming adjacent normal skin cells in two different models of BCC. " 11/16/2022 - "Murine studies showed that the topical delivery of sonidegib, itraconazole, vitamin D₃ and CUR-61414 led to biological responses and tumor remission. "